title: Synthesis, Antimicrobial and Antiinflammatory Activity of 2,5-Disubstituted-1,3,4-oxadiazoles.
abstract: In the present study, 2,5-disubstituted-1,3,4-oxadiazoles (3a-o) have been synthesized by the condensation of 4-methoxybenzohydrazide (1) with different aromatic acids (2a-o) in presence of phosphoryl chloride. The structural assignment of this compound (3a-o) has been made on the basis of elemental analysis, UV, IR, (1)H NMR and mass spectral data. The synthesized compounds were screened for their in vitro growth inhibiting activity against different strains of bacteria and fungi viz., Staphylococcus aureus, Bacillus subtilis, Bacillus megaterium, Escherichia coli, Pseudomonas aeruginosa, Shigella dysenteriae, Candida albicans, Aspergillus niger and Aspergillus flavus were compared with the standard antibiotics such as chloramphenicol (50 mug/ml) and griseofulvin (50 mug/ml) using well agar diffusion technique. Compounds 3e, 3g, 3h and 3m exhibits highest antibacterial activity and compounds 3d, 3g and 3h showed better antifungal activity. The synthesized compounds (3a-o) were screened for their in vitro antiinflammatory activity against carrageenan-induced rat paw oedema. Compounds 3f and 3i were found to be most active compound of this series, which shows 46.42% and 50% inflammation inhibitory activity, whereas standard drug phenylbutazone exhibit 53.57% antiinflammatory activity at a dose of 50 mg/kg po.
authors.affiliation: Department of Pharmaceutical Chemistry, The Erode College of Pharmacy, Vallipurathanpalayam post, Erode - 638 112, India.
authors.forename: G
authors.initials: G
authors.lastname: Nagalakshmi
references.citation: N Engl J Med. 1991 Jun 13;324(24):1716-25
references.pmid: 2034249
references.citation: Bioorg Med Chem. 2004 Oct 1;12(19):5107-13
references.pmid: 15351394
references.citation: Pharmazie. 1994 Dec;49(12):880-4
references.pmid: 7838878
references.citation: J Agric Food Chem. 2003 Jan 1;51(1):152-5
references.pmid: 12502400
references.citation: Mol Cancer Ther. 2005 May;4(5):761-71
references.pmid: 15897240
references.citation: J Med Chem. 1966 Jul;9(4):478-83
references.pmid: 5968010
references.citation: Arch Pharm (Weinheim). 2000 Mar;333(2-3):53-7
references.pmid: 10783518
references.citation: J Med Chem. 1993 Apr 16;36(8):1090-9
references.pmid: 8478906
references.citation: Proc Soc Exp Biol Med. 1962 Dec;111:544-7
references.pmid: 14001233
references.citation: Eur J Med Chem. 2002 Mar;37(3):197-206
references.pmid: 11900864
references.citation: Annu Rev Immunol. 1983;1:335-59
references.pmid: 6399978
references.citation: Pol J Pharmacol. 2002 Jan-Feb;54(1):55-9
references.pmid: 12020044
references.citation: FASEB J. 1987 Aug;1(2):89-96
references.pmid: 3111928